<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>Sa Transcripts on Finance Insights Daily</title><link>https://finance.dpfeed.com/tags/sa-transcripts/</link><description>Recent content in Sa Transcripts on Finance Insights Daily</description><image><title>Finance Insights Daily</title><url>https://finance.dpfeed.com/images/finance-insights-og.jpg</url><link>https://finance.dpfeed.com/images/finance-insights-og.jpg</link></image><generator>Hugo -- 0.147.7</generator><language>en-us</language><lastBuildDate>Sun, 17 May 2026 07:44:08 +0000</lastBuildDate><atom:link href="https://finance.dpfeed.com/tags/sa-transcripts/index.xml" rel="self" type="application/rss+xml"/><item><title>Imerys: Investor Insights &amp; Future Prospects Unveiled</title><link>https://finance.dpfeed.com/posts/imerys-investor-insights-future-prospects-unveiled/</link><pubDate>Sun, 17 May 2026 07:44:08 +0000</pubDate><guid>https://finance.dpfeed.com/posts/imerys-investor-insights-future-prospects-unveiled/</guid><description>Financial analysis and investment insights on Imerys S.A. (IMYSY) Shareholder/Analyst Call - Slideshow for smart investors.</description></item><item><title>Eurazeo's Q1 2026: Unpacking Sales &amp; Trading Momentum</title><link>https://finance.dpfeed.com/posts/eurazeo-s-q1-2026-unpacking-sales-trading-momentum/</link><pubDate>Wed, 13 May 2026 08:11:58 +0000</pubDate><guid>https://finance.dpfeed.com/posts/eurazeo-s-q1-2026-unpacking-sales-trading-momentum/</guid><description>Financial analysis and investment insights on Eurazeo SE (EUZOF) Q1 2026 Sales/ Trading Statement Call - Slideshow for smart investors.</description></item><item><title>Ulcerative Colitis Breakthrough: SPY001 Shows Promising SKYLINE Trial Results</title><link>https://finance.dpfeed.com/posts/ulcerative-colitis-breakthrough-spy001-shows-promising-skyline-trial-results/</link><pubDate>Tue, 14 Apr 2026 07:01:10 +0000</pubDate><guid>https://finance.dpfeed.com/posts/ulcerative-colitis-breakthrough-spy001-shows-promising-skyline-trial-results/</guid><description>Financial analysis and investment insights on Spyre Therapeutics, Inc. (SYRE) Discusses SPY001 Part A Induction Topline Results From SKYLINE Trial in Moderate-t</description></item><item><title>FREEDOM2: PEPG's Lowest Dose Shows Promising Safety and Efficacy.</title><link>https://finance.dpfeed.com/posts/freedom2-pepg-s-lowest-dose-shows-promising-safety-and-efficacy/</link><pubDate>Tue, 31 Mar 2026 06:43:42 +0000</pubDate><guid>https://finance.dpfeed.com/posts/freedom2-pepg-s-lowest-dose-shows-promising-safety-and-efficacy/</guid><description>Financial analysis and investment insights on PepGen Inc. (PEPG) Discusses Topline Results From Lowest Dose MAD Cohort in Phase II FREEDOM2 Study With Favorable</description></item><item><title>Karyopharm's SENTRY Trial: Myelofibrosis Breakthrough Unveiled</title><link>https://finance.dpfeed.com/posts/karyopharm-s-sentry-trial-myelofibrosis-breakthrough-unveiled/</link><pubDate>Wed, 25 Mar 2026 06:13:48 +0000</pubDate><guid>https://finance.dpfeed.com/posts/karyopharm-s-sentry-trial-myelofibrosis-breakthrough-unveiled/</guid><description>Financial analysis and investment insights on Karyopharm Therapeutics Inc. (KPTI) Discusses Top Line Results From Phase III SENTRY Trial in Myelofibrosis - Slid</description></item><item><title>EMANATE Trial: Rhythm Pharma Shares Breakthrough Phase 3 Insights</title><link>https://finance.dpfeed.com/posts/emanate-trial-rhythm-pharma-shares-breakthrough-phase-3-insights/</link><pubDate>Tue, 17 Mar 2026 06:12:48 +0000</pubDate><guid>https://finance.dpfeed.com/posts/emanate-trial-rhythm-pharma-shares-breakthrough-phase-3-insights/</guid><description>Financial analysis and investment insights on Rhythm Pharmaceuticals, Inc. (RYTM) Discusses Topline Results and Insights from Phase 3 EMANATE Trial Transcript f</description></item><item><title>Kyivstar's Q4 2025: Unpacking the Latest Financial Report</title><link>https://finance.dpfeed.com/posts/kyivstar-s-q4-2025-unpacking-the-latest-financial-report/</link><pubDate>Sat, 14 Mar 2026 06:00:17 +0000</pubDate><guid>https://finance.dpfeed.com/posts/kyivstar-s-q4-2025-unpacking-the-latest-financial-report/</guid><description>Financial analysis and investment insights on Kyivstar Group Ltd. (KYIV) Q4 2025 Earnings Call Transcript for smart investors.</description></item><item><title>Lufthansa's 2025 Q4: Unpacking the Earnings Powerhouse</title><link>https://finance.dpfeed.com/posts/lufthansa-s-2025-q4-unpacking-the-earnings-powerhouse/</link><pubDate>Sat, 07 Mar 2026 05:51:54 +0000</pubDate><guid>https://finance.dpfeed.com/posts/lufthansa-s-2025-q4-unpacking-the-earnings-powerhouse/</guid><description>Financial analysis and investment insights on Deutsche Lufthansa AG 2025 Q4 - Results - Earnings Call Presentation for smart investors.</description></item><item><title>Hays plc: H1 2026 Investor Insights Unveiled</title><link>https://finance.dpfeed.com/posts/hays-plc-h1-2026-investor-insights-unveiled/</link><pubDate>Sat, 28 Feb 2026 05:49:16 +0000</pubDate><guid>https://finance.dpfeed.com/posts/hays-plc-h1-2026-investor-insights-unveiled/</guid><description>Financial analysis and investment insights on Hays plc (HAYPY) H1 2026 Sales/ Trading Statement Call - Slideshow for smart investors.</description></item><item><title>Genmab Unlocks 2025: R&amp;D, ASH Data, Pipeline Strategy Revealed</title><link>https://finance.dpfeed.com/posts/genmab-unlocks-2025-r-d-ash-data-pipeline-strategy-revealed/</link><pubDate>Fri, 12 Dec 2025 05:37:30 +0000</pubDate><guid>https://finance.dpfeed.com/posts/genmab-unlocks-2025-r-d-ash-data-pipeline-strategy-revealed/</guid><description>Financial analysis and investment insights on Genmab A/S (GMAB) Discusses 2025 R&amp;amp;D Progress, ASH Data Review, and Strategic Pipeline Additions - Slideshow for s</description></item><item><title>Unlock Koppers' Potential: Sidoti Virtual Investor Conference</title><link>https://finance.dpfeed.com/posts/unlock-koppers-potential-sidoti-virtual-investor-conference/</link><pubDate>Thu, 11 Dec 2025 05:38:59 +0000</pubDate><guid>https://finance.dpfeed.com/posts/unlock-koppers-potential-sidoti-virtual-investor-conference/</guid><description>Financial analysis and investment insights on Koppers Holdings Inc. (KOP) Presents at Sidoti Year End Virtual Investor Conference - Slideshow for smart investor</description></item><item><title>CVS Health's Next Chapter: Investor Day Strategy Slides</title><link>https://finance.dpfeed.com/posts/cvs-health-s-next-chapter-investor-day-strategy-slides/</link><pubDate>Wed, 10 Dec 2025 05:36:28 +0000</pubDate><guid>https://finance.dpfeed.com/posts/cvs-health-s-next-chapter-investor-day-strategy-slides/</guid><description>Financial analysis and investment insights on CVS Health Corporation (CVS) Analyst/Investor Day - Slideshow for smart investors.</description></item><item><title>Endava (DAVA) Reveals 2025 Ultimate Services Investor Strategy</title><link>https://finance.dpfeed.com/posts/endava-dava-reveals-2025-ultimate-services-investor-strategy/</link><pubDate>Wed, 19 Nov 2025 05:34:39 +0000</pubDate><guid>https://finance.dpfeed.com/posts/endava-dava-reveals-2025-ultimate-services-investor-strategy/</guid><description>Financial analysis and investment insights on Endava plc (DAVA) Presents at J.P. Morgan 2025 Ultimate Services Investor Conference Transcript for smart investor</description></item></channel></rss>